You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A rationally-designed, live-attenuated RSV vaccine for the elderly
SBC: Codagenix Inc. Topic: NIAIDPROJECT SUMMARY/ABSTRACT Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover within two weeks, but RSV is the most common cause of bronchiolitis and pneumonia in children under one year of age, and leads to hospitalization of ~177,000 adults aged 65 and older of which ~14,000 die annually. Despite many attempts, a vaccin ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Development and Commercialization of a Tau Oligomer Inhibitor for AD/RD
SBC: OLIGOMERIX INC Topic: RPROJECT SUMMARY: This R44 supplement application is focused on the development of a comprehensive publication strategy to meet the company’s long-standing goal of disseminating its findings to the scientific community. The proposed work is designed to create a long term publication plan for the company which will include the writing and publishing of (2) manuscripts during the project term. The ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Automating and Obtaining FDA Approval for a Digital Intervention for Depression
SBC: HEALTH RHYTHMS INC Topic: 104Phase IIB Abstract -FINAL A large body of evidence supports the idea that disruptions in the regularity of behavioral routines (or ‘social rhythms’) can lead to the onset of mood symptoms and full-blown episodes via their impact on endogenous circadian rhythms and, conversely, that stable social routines protect against new mood episodes. Based on our conviction that monitoring, evaluating, an ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
A Novel Recombinant Protein for Mitigating Acute Radiation Injury
SBC: THERASOURCE, LLC Topic: NIAIDPROJECT DESCRIPTION: This SBIR Phase II proposal is intended to further develop recombinant human MFG-E8 (rhMFG-E8) as a radiation medical countermeasure (MCM) towards its approval by the FDA in the future. Nuclear terrorism and major nuclear power plant leaks can cause acute radiation injury on a large scale. Currently, there are limited drugs available to treat acute radiation syndrome (ARS). rh ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
An RSV Prefusion F Vaccine that Overcomes Immunosenescence
SBC: Calder Biosciences Inc. Topic: NIARespiratory Syncytial Virus (RSV) infection in the elderly causes great human suffering due to hospitalization and death, and is considered a societal burden similar to that of seasonal influenza. Vaccines for the prevention of RSV infections are not yet available, and development efforts are made all the more difficult in the elderly due to age-associated immunosenescence that impairs their abili ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Anti-Fibrotic Therapy for Scleroderma/SSc
SBC: Angion Biomedica Corp. Topic: NIAMSDESCRIPTION (provided by applicant): Scleroderma (also known as systemic sclerosis-SSc) is characterized primarily by progressive dermal and vascular fibrosis. Other organs are affected too, including lung, heart, blood vessels, GI and kidney. Many patients who suffer from scleroderma/SSc also have a loss of pulmonary function. Scleroderma/SSc affects approximately 400,000 to 900,000 people in th ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Phase II Clinical Trial of G207 HSV To Treat Children with High Grade Gliomas
SBC: Treovir, Inc. Topic: NCITreovir, LLC is requesting Small Business Innovation Research (SBIR) support to conduct a single arm Phase II clinical trial in children (age 3-18 years) who have been diagnosed with recurrent or progressive high grade glioma (HGG). We propose to determine efficacy of a cGMP-produced (clinical grade) G207 Herpes Simplex Virus (HSV) in children with recurrent HGG. Our rationale is based on a Phase ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Neuro-exergaming for the prevention and remediation of decline due to Alzheimer's disease and related dementias: A clinical trial of the interactive Physical and Cognitive Exercise System (iPACES v3)
SBC: iPACES LLC Topic: NIAProject Summary/Abstract (30 lines)We are pleased to submit this technical and business assistance (TABA) funding as an administrative supplement to our on-going DP2 SBIR: “Neuro-exergaming for the prevention and remediation of decline due to Alzheimer's disease and related dementias: A clinical trial of the interactive Physical and Cognitive Exercise System (iPACES v3).” We are in the midst o ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
DEVELOPMENT OF A LIPOSOMAL PNEUMOCOCCAL VACCINE FOR CLINICAL READINESS
SBC: Abcombi Biosciences Inc Topic: NIAIDPROJECT SUMMARYThe illnesses caused by Streptococcus pneumoniae’s transition from carriage to disease result in a mortality rate between approximately 3-10% in adults and 12-25% in elderly patients in the United States. Furthermore, pneumococcal disease devastates resource-poor countries, causing an estimated 476,000 people to succumb to pneumococcal infection annually (~32% of vaccine-preventab ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
EXTENDING INDEPENDENCE AND QUALITY OF LIFE FOR PEOPLE WITH ALZHEIMER'S DISEASE OR DEMENTIA THROUGH TELEHEALTH PROGRAM DELIVERY
SBC: Together Senior Health, Inc. Topic: NIAMission Statement: Together Senior Health, Inc. (TOGETHER), is committed to helping people living with Alzheimer’s Disease and Related Disorders (ADRD) and their caregivers maximize quality of life by delivering livestreaming, evidence-based, virtual group programs to them in their homes. Significance: There are currently 5.8 million people in the U.S. living with ADRD and more than 16 million u ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health